Comet Therapeutics
About:
Comet Therapeutics is a developer of therapies designed to treat orphan neurological disorders.
Website: https://comettherapeutics.com/
Twitter/X: comettx1
Top Investors: Sofinnova Partners, Mission BioCapital, Canaan Partners, Inkef
Description:
CoEnzyme is a developer of therapies designed to treat orphan neurological disorders. The company develops a treatment to restore dysregulated CoEnzyme A metabolism through its CoEnzyme metabolism platform, enabling physicians to address the profound unmet medical needs.
Total Funding Amount:
$28.5M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2018-01-01
Founders:
Enej Kuscer
Number of Employees:
1-10
Last Funding Date:
2019-06-19
IPO Status:
Private
Industries:
© 2025 bioDAO.ai